Repligen Corporation – Filings and Transcripts

NASDAQ: RGEN
Share price (2/27/26): $128.73
Market cap (2/27/26): $7.252 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Prospectus with selling stockholder info

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Price T Rowe Associates Inc

Roy T. Eddleman Living Trust

Douglass Brian Robb

Douglass Brian Robb

News Filter

Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance

Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair

Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Reports Second Quarter 2025 Financial Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Letter from the SEC